ObsEva SA (OBSEF)

Market Cap	11.72K +9,915.4%
Revenue (ttm)	19.64M -11.5%
Net Income	7.92M
EPS	0.07
Shares Out	117.18M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,130
Average Volume	20,998
Open	0.0001
Previous Close	0.0002
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	14.16
RSI	51.03
Earnings Date	n/a

About ObsEva

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: OBSEF

Financial Performance

In 2022, ObsEva's revenue was $19.64 million, a decrease of -11.55% compared to the previous year's $22.20 million. Losses were -$29.88 million, -43.60% less than in 2021.